Earth Science Tech Inc. (OTC: ETST) announced fiscal year 2026 results for the year ended March 31, 2026, demonstrating growth across key financial metrics as the company continues to execute its diversified holdings model spanning healthcare, pharmaceuticals, telemedicine, real estate and consumer businesses. Revenue increased 8% to $35.7 million, gross profit rose 5% to $25.5 million, net income grew 11% to $3.6 million, and total assets increased 27% to $9 million.
CEO Giorgio R. Saumat attributed the results to the company’s efforts to fully integrate the patient experience across telemedicine, pharmacy and fulfillment. The core of Earth Science Tech’s value proposition lies in the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of its specialized subsidiaries. The company operates as a diversified holding company focused on the health and wellness sector, with a principal operating strategy to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support and direct-to-patient fulfillment.
The company’s healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business. The results highlight the momentum behind Earth Science Tech’s end-to-end platform connecting telemedicine, pharmacy and fulfillment, which aims to streamline the patient journey and enhance outcomes. For more details on the company’s strategy and recent developments, visit the full article at https://nnw.fm/u6mhk.
Investors can keep up with the latest news and updates relating to ETST in the company’s newsroom at https://nnw.fm/ETST. Additional information about Earth Science Tech is available at www.EarthScienceTech.com.
